Overexpression of the neuritotrophic cytokine S100β precedes the appearance of neuritic β-amyloid plaquesin APPV717F mice

Journal of Neurochemistry

Volumn 74, Issue 1, 2000, Pages 295-301

  Sheng, J G ^a,h   Mrak, R E ^b,e   Bales, K R ^f   Cordell, B ^g   Paul, S M ^f   Jones, R A ^c   Woodward, S ^a   Zhou, X Q ^a   McGinness, J M ^a   Griffin, W S T ^a,b,c,d,e  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Dept of Vet' Aff Medical Center ^*  (United States)

^d Education and Clinical Center   (United States)

^e CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^f ELI LILLY AND COMPANY   (United States)

^g Scios   (United States)

^h SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Amyloid; Amyloid precursor protein; Aging; Alzheimer's disease; APPV717F mice; Astrocytes; Cytokines; Inflammation; PDAPP mice; S100 ; Transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN; PROTEIN PRECURSOR;

ADOLESCENT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CELL GROWTH; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; MOUSE; NEURITE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AGING; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; NEURITES; RNA, MESSENGER; S100 PROTEINS; SENILE PLAQUES;

MUS MUSCULUS;

EID: 0033983967     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0740295.x     Document Type: Article

References (32)

1. Barger S. W. and Harmon A. D. (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388, 878-881.
2. Buxbaum J. D., Oishi M., Chen H. I., Pinkas-Kramarski R., Jaffe E. A., Gandy S. E., and Greengard P. (1992) Cholinergic agonists and interleukin I regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA 89, 10075-10078.
3. da Cunha A., Jefferson J. J., Tyor W. R., Glass J. D., Jannotta F. S., and Vitkovic L. (1993) Gliosis in human brain: relationship to size but not other properties of astrocytes. Brain Res. 600, 161-165.
4. Esiri M. M., Biddolph S. C., and Morris C. S. (1998) Prevalence of Alzheimer plaques in AIDS. J. Neurol. Neurosurg. Psychiatry 65, 29-33.
5. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Muck L., Paganini L., and Penniman E. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
6. Giulian D., Woodward J., Young D. G., Krebs J. F., and Lachman L. B. (1988) Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8, 2485-2490.
7. Griffin W. S. T., Stanley L. C., Ling C., White C. L. III, and Araoz C. (1989) Brain interleukin-1 and S100 immunoreactivity elevated in Down syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615.
8. Griffin W. S. T., Sheng J. G., Gentleman S. M., Graham D. I., Mrak R. E., and Roberts G. W. (1994) Microglial interleukin-1α expression in human head injury: correlations with neuronal and neuritic β-amyloid precursor protein expression. Neurosci. Lett. 176, 133-136.
9. Griffin W. S. T., Yeralan O., Sheng J. G., Boop F. A., Mrak R. E., Rovnaghi C. R., Burnett B. A., Feoktistova A., and Van Eldik L. C. (1995) Overexpression of the neurotrophic cytokine S100β in human temporal lobe epilepsy. J. Neurochem. 65, 228-233.
10. Griffin W. S. T., Graham D. I., McKenzie J. E., Royston M. C., Mrak R. E., and Gentleman S. M. (1997) S100β immunoreactivity following fatal head injury. (Abstr.) J. Neurotrauma 15, 52.
11. Griffin W. S. T., Sheng J. G., McKenzie J., Royston M. C., Gentleman S. M., Brumback R. A., Cork L. C., Del Bigio M. R., Roberts G. W., and Mrak R. E. (1998a) Life-long overexpression of S100β in Down's syndrome: implications for Alzheimer pathogenesis. Neurobiol. Aging 19, 401-405.
12. Griffin W. S. T., Sheng J. G., and Mrak R. E. (1998b) Senescence-accelerated overexpression of S100β in brain of SAMP6 mice. Neurobiol. Aging 19, 71-76.
13. Griffin W. S. T., Sheng J. G., Royston M. C., Gentleman S. M., McKenzie J. E., Graham D. I., Roberts G. W., and Mrak R. E. (1998c) Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 8, 65-72.
14. Hof P. R., Giannakopoulos P., and Bouras C. (1996) The neuropathological changes associated with normal brain aging. Histol. Histopathol. 11, 1075-1088.
15. Kato K., Suzuki F., Morishita R., Asano T., and Sato T. (1990) Selective increase in S100β protein by aging in rat cerebral cortex. J. Neurochem. 54, 1269-1274.
16. Kligman D. and Marshak D. R. (1985) Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. USA 82, 7136-7139.
17. Kowall N. W., McKee A. C., Yankner B. A., and Beal M. F. (1992) In vivo neurotoxicity of β-amyloid [β(1-40)] and the β (25-35) fragment. Neurobiol. Aging 13, 537-542.
18. Li Y., Wang J., Sheng J. G., Liu L., Barger S. W., Jones R. A., Van Eldik L. J., Mrak R. E., and Griffin W. S. T. (1998) S100ß increases levels of β-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J. Neurochem. 71, 1421-1428.
19. Mackenzie I. R. A. and Miller L. A. (1994) Senile plaques in temporal lobe epilepsy. Acta Neuropathol. (Berl.) 87, 504-510.
20. Marshak D. R., Pesce S. A., Stanley L. C., and Griffin W. S. T. (1991) Increased S100β neurotrophic activity in Alzheimer disease temporal lobe. Neurobiol. Aging 13, 1-7.
21. Mayeux R., Ottman R., Tang M. X., Noboa-Bauza L., Marder K., Gurland B., and Stern Y. (1993) Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann. Neurol. 33, 494-501.
22. McKee A. C., Kowall N. W., Schumacher J. S., and Beal M. F. (1998) The neurotoxicity of amyloid β protein in aged primates. Amyloid Int. J. Exp. Clin. Invest. 5, 1-9.
23. Mortimer J. A., van Duijn C. M., Chandra V., Fratiglioni L., Graves A. B., Heyman A., Jorm A. F., Kokmen E., Kondo K., Rocca W. A., et al. (1991) Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20 (Suppl.), S28-S35.
24. Mrak R. E., Sheng J. G., and Griffin W. S. T. (1996) Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55, 273-279.
25. Royston M. C., McKenzie J. E., Gentleman S. M., Sheng J. G., Mann D. M. A., Griffin W. S. T., and Mrak R. F. (1999) Overexpression of S100β in Down's syndrome: correlation with patient age and with β-amyloid deposition. Neuropathol. Appl. Neurobiol. (in press).
26. Sheng J. G., Mrak R. E., and Griffin W. S. T. (1994) S100β protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39, 398-404.
27. Sheng J. G., Ito K., Skinner R. D., Mrak R. E., Rovnaghi C. R., Van Eldik L. J., and Griffin W. S. T. (1996a) In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 17, 761-766.
28. Sheng J. G., Mrak R. E., Rovnaghi C. R., Kozlowska E., Van Eldik L., J., and Griffin W. S. T. (1996b) Human brain S100β and S100β mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol. Aging 17, 359-363.
29. Stanley L. C., Mrak R. E., Woody R. C. and Griftin W. S. T. (1994) Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J. Neuropathol. Exp. Neurol. 53, 231-238.
30. Stein-Behrens B., Adams K., Yeh M., and Sapolsky R. (1992) Failure of β-amyloid protein fragment 25-35 to cause hippocampal damage in the rat. Neurobiol. Aging 13, 577-579.
31. Troncoso J. C., Martin L. J., Dal Forno G., and Kawas C. H. (1996) Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol. Aging 17, 365-371.
32. Van Eldik L. J. and Griffin W. S. T. (1994) S100β expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim. Biophys. Acta 1223, 298-403.